These benefits, together with a former report demonstrating that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like habits in mice,2 support the thought of focusing on ACKR3 as a unique solution to modulate the opioid process, which could open up new therapeutic avenues for opioid-relevant Diseases. Title your collection: Title https://jamesk690skb3.ziblogs.com/profile